- Home
- CVS vs GSK Comparison
CVS vs GSK Comparison
Compare CVS & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVS | GSK |
|---|---|---|
| Founded | 1963 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.4B | 100.0B |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CVS | GSK |
|---|---|---|
| Price | $87.22 | $46.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 27 | 8 |
| Target Price | ★ $116.28 | $59.58 |
| AVG Volume (30 Days) | ★ 6.7M | 2.9M |
| Earning Date | 10-28-2026 | 10-28-2026 |
| Dividend Yield | 3.08% | ★ 3.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.61 | N/A |
| Revenue | ★ $402,067,000,000.00 | N/A |
| Revenue This Year | $4.56 | $3.84 |
| Revenue Next Year | $2.85 | $4.65 |
| P/E Ratio | ★ $18.48 | $32.75 |
| Revenue Growth | ★ 7.85 | N/A |
| 52 Week Low | $69.51 | $42.85 |
| 52 Week High | $110.68 | $61.70 |
Technical Indicators
Market Signals| Indicator | CVS | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 39.27 | 31.93 |
| Support Level | $73.86 | N/A |
| Resistance Level | $98.15 | $51.60 |
| Average True Range (ATR) | 2.06 | 0.75 |
| MACD | -0.15 | -0.29 |
| Stochastic Oscillator | 24.83 | 5.91 |
Price Performance
Historical ComparisonAbout CVS CVS Health Corporation
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.